Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sub-Study to Assess the Choroidal Response to Novel Spectacle Lens to Control Myopia Progression (CHERRY)

NCT03818880 is registered in ClinicalTrials.gov with SightGlass Vision, Inc. as lead sponsor.

NCT NCT03818880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03818880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sub-Study to Assess the Choroidal Response to Novel Spectacle Lens to Control Myopia Progression (CHERRY)
Lead sponsor
SightGlass Vision, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 18, 2018
Completion date
December 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia, progressive